However, the difference in phosphorylation of ShcA at Tyr313 is more dramatic between the two tumour types (Figure 4e), with the c-ErbB2 tumours having more ShcA phosphorylated at Tyr313 than the bitransgenic tumours suggesting that activities regulated by phosphorylation of this site (cell survival) may be less important in the tumours that express activated Akt1. Here, SHC1 is linked to neoplasm.